课题基金 / 基金详情

A population-based assessment of the cardiovascular effects of 5-alpha reductase inhibitors

A population-based assessment of the cardiovascular effects of 5-alpha reductase inhibitors
基于人群的 5-α 还原酶抑制剂心血管效应评估
批准号：
303555
负责人：
Filion Kristian B
金额：
$11.31万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-03-01 至 2016-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=303555&lang=en
关键词：
5-Alpha Reductase Inhibitors Benign Prostatic Hyperplasia Cardiovascular Disease Drug Safety Heart Failure Myocardial Infarction Pharmacoepidemiology Side Effects Stroke

项目摘要

项目成果

Filion Kristian B的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The class of drugs called 5-alpha reductase inhibitors are commonly used to treat men with enlarged prostates, a condition called benign prostatic hyperplasia or BPH. Previous studies have shown that these drugs improve the symptoms of BPH and decrease th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparative Effectiveness of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin for the Prevention of Micro- and Macrovascular Complications Among Patients with Type 1 Diabetes
The Safety of Antipsychotic Drugs Among Children and Youth With Attention Deficit and Hyperactivity Disorder
Comparative Effectiveness and Safety of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin among Patients with Type 2 Diabetes
A population-based assessment of pharmacological treatments for gestational diabetes
海外基金